Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 9/20 | 1.00 |
| ▸ | THRB | P10828 | 9/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 9/20 | 1.00 |
| ▸ | BLM | P54132 | 8/20 | 1.00 |
| ▸ | RECQL | P46063 | 7/20 | 1.00 |
| ▸ | MAPT | P10636 | 6/20 | 1.00 |
| ▸ | HTT | P42858 | 5/20 | 1.00 |
| ▸ | TDP1 | Q9NUW8 | 5/20 | 1.00 |
| ▸ | APEX1 | P27695 | 3/20 | 1.00 |
| ▸ | BRCA1 | P38398 | 6/20 | 0.87 |
| ▸ | SMN1; SMN2 | Q16637 | 6/20 | 0.87 |
| ▸ | HIF1A | Q16665 | 6/20 | 0.87 |
| ▸ | MAPK1 | P28482 | 5/20 | 0.87 |
| ▸ | S100A4 | P26447 | 5/20 | 0.87 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.87 |
| ▸ | USP2 | O75604 | 4/20 | 0.87 |
| ▸ | CYP1A2 | P05177 | 4/20 | 0.87 |
| ▸ | CHRM1 | P11229 | 4/20 | 0.87 |
| ▸ | TOP2A | P11388 | 4/20 | 0.87 |
| ▸ | STAT6 | P42226 | 4/20 | 0.87 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Carubicin SCHEMBL6343014 | 1.00 | MEN1 (1.00) | MEN1THRBKMT2ABLMRECQL | |
| Carubicin SCHEMBL29362266 | 1.00 | MEN1 (1.00) | MEN1THRBKMT2ABLMRECQL | |
| Carubicin SCHEMBL12202628 | 1.00 | MEN1 (1.00) | MEN1THRBKMT2ABLMRECQL | |
| Carubicin SCHEMBL6343007 | 1.00 | MEN1 (1.00) | MEN1THRBKMT2ABLMRECQL | |
| Carubicin SCHEMBL1650594 | 1.00 | MEN1 (1.00) | MEN1THRBKMT2ABLMRECQL | |
| Carubicin SCHEMBL23300868 | 1.00 | MEN1 (1.00) | MEN1THRBKMT2ABLMRECQL | |
| Carubicin SCHEMBL18389599 | 1.00 | MEN1 (1.00) | MEN1THRBKMT2ABLMRECQL | |
| Carubicin SCHEMBL29357994 | 0.99 | MEN1 (0.98) | MEN1THRBKMT2ABLMRECQL | |
| Carubicin SCHEMBL29355094 | 0.99 | MEN1 (0.98) | MEN1THRBKMT2ABLMRECQL | |
| Carubicin SCHEMBL4201 | 0.99 | MEN1 (0.98) | MEN1THRBKMT2ABLMRECQL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 24493 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4748859-A2 | CHEMICALLY AND PHOTOCHEMICALLY INITIATED CELL MEMBRANE BLEBBING TO INDUCE CELL VESICLE PRODUCTION, MODIFICATIONS THEREOF, AND USES THEREOF | The Regents of the University of California (US) | 2026-05-27 | — | — | EP | claimed |
| US-20260137794-A1 | LIGAND-DRUG CONJUGATE AND USE THEREOF | SYSTIMMUNE INC (US) | 2026-05-21 | — | — | US | claimed |
| US-12630593-B2 | Method of killing leukemia cells by administration of recombinant'Y3 proteins | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED (US) | 2026-05-19 | — | — | US | claimed |
| US-20260115305-A1 | LINKERS, CONJUGATES AND APPLICATIONS THEREOF | GENEQUANTUM HEALTHCARE SUZHOU CO LTD (CN) | 2026-04-30 | — | — | US | claimed |
| US-20260108619-A1 | CONJUGATION LINKERS, CELL BINDING MOLECULE-DRUG CONJUGATES CONTAINING THE LINKERS, METHODS OF MAKING AND USES SUCH CONJUGATES WITH THE LINKERS | HANGZHOU DAC BIOTECH CO., LTD. (CN) | 2026-04-23 | — | — | US | claimed |
| US-20260077056-A1 | LINKER-PAYLOAD COMPOUND, CONJUGATES AND APPLICATIONS THEREOF | GENEQUANTUM HEALTHCARE SUZHOU CO LTD (CN) | 2026-03-19 | — | — | US | claimed |
| US-12576124-B2 | Formulation of a conjugate of a tubulysin analog to a cell-binding molecule | HANGZHOU DAC BIOTECH CO., LTD (CN) | 2026-03-17 | — | — | US | claimed |
| EP-4694909-A1 | METHODS OF MODULATING THE EPITHELIAL-MESENCHYMAL TRANSITION | RS Oncology, LLC (US) | 2026-02-18 | — | — | EP | claimed |
| EP-4694935-A1 | COMBINATION OF ANTIBODY-DRUG CONJUGATE AND ANTI-PD-1 ANTIBODY, AND USE THEREOF | Genequantum Healthcare (Suzhou) Co., Ltd. (CN) | 2026-02-18 | — | — | EP | claimed |
| EP-4688871-A1 | SITE-SPEICFIC ORTHOGONAL BIOCONJUGATE MODALITY AND APPLICATION THEREOF | Genequantum Healthcare (Suzhou) Co., Ltd. (CN) | 2026-02-11 | — | — | EP | claimed |
| EP-0398305-A2 | Anthracycline conjugates having a novel linker and methods for their production | Bristol-Myers Squibb Company (US) | 1990-11-22 | — | — | EP | claimed |
| EP-0226173-B1 | ANTHRACYCLINS AND MEDICINES CONTAINING THEM | LABORATOIRES HOECHST S.A. (FR) | 1990-03-14 | — | — | EP | claimed |
| US-4877870-A | HYDROXYLATION; REACTING WITH AMINE OXIDE; ANTITUMOR AGENTS | KIRIN BEER KABUSHIKI KAISHA (JP) | 1989-10-31 | — | — | US | claimed |
| EP-0328147-A2 | Anthracycline immunoconjugates having a novel linker and methods for their production | Bristol-Myers Squibb Company (US) | 1989-08-16 | — | — | EP | claimed |
| EP-0302473-A2 | Antibody-enzyme conjugates in combination with prodrugs for the delivery of cytotoxic agents to tumor cells | Bristol-Myers Squibb Company (US) | 1989-02-08 | — | — | EP | claimed |
| EP-0226173-A1 | Anthracyclins and medicines containing them | LABORATOIRES HOECHST S.A. (FR) | 1987-06-24 | — | — | EP | claimed |
| US-4331648-A | CARDIOTONIC AGENTS; MOUTH | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1982-05-25 | — | — | US | claimed |
| US-4320110-A | Carnitine and its use in reducing cardiac toxicity and as a synergist with cytostats | FELICE STEPHEN L DE | 1982-03-16 | — | — | US | claimed |
| US-4189568-A | MULTISTEP SOLVENT EXTRACTION OF FERMEMTATION SOLIDS, COUNTERCURRENT DISTRIBUTION, CHROMATOGRAPHY | BRISTOL-MYERS COMPANY (US) | 1980-02-19 | — | — | US | claimed |
| US-4188377-A | TREATMENT OF LEUKEMIA; SYNTHETIC ANTHRACYCLINE ANTIBIOTIC HAVING LOWERED TOXICITY | FARMITALIA CARLO ERBA S.P.A. (IT) | 1980-02-12 | — | — | US | claimed |